Funds to be used for early detection of HLB disease
"This system and technology will offer great flexibility in meeting both CRB's and the citrus industries Point of Analysis HLB early disease detection and monitoring needs in preventing the disease to take over the citrus industry," said Alan Jernigan, CEO of EZDiagnostix, Inc., a subsidiary of APNT designated for the commercialization of the agricultural pathology and healthcare applications of the EZKnowz technology. "They can be utilized to provide near instantaneous information for detecting the HLB bacteria asymptomatically, as well as, provide tools for the growers to get ahead of the spread of the disease."
"The advancement of this technology fills a critical need for the continued production of citrus worldwide," reported Ted Batkin, president of the Citrus Research Board. "HLB has caused severe damage to citrus production regions in Asia, South America, Mexico and the United States. The ability to detect the disease early in its life cycle will allow the industry to develop management strategies to prevent spread and maintain financial viability."
"These new contracts are important to accelerating commercial development of our technology and will be important in combating a growing problem in the citrus industry,” said Jernigan.
HLB is considered to be the highest threat to all citrus production regions worldwide. More information can be found at the CRB Website: www.citrusresearch.org.